Amarin Corp Plc (AMRN)

[couldbebetter]

Gbert, Appreciate your efforts. My take is that insurance companies do
not know nor do they care if they are infringing or not. Their goal is
to reduce costs and ironically many generic Vascepa scrips may end up
being filled as generic Lovaza because it is far cheaper than generic
Vascepa. If they infringe with generic Vascepa they do not care as there
is really no penalty for them...if they can get the scrip filled with
generic Lovaza even better because that is really cheap. This is one
more reason why AMRN should have been sold long ago to a BP that has
the legal clout to go after infringers and might have the gravitas with
the FDA to get them to enact an administrative solution to the problem.
(My guess is for some reason JT is very fearful of the FDA and will not
make any waves with them.) If Pfizer or JNJ owned this they would get
the FDA to find a solution. What is strange is that this is a very real
health issue with very real lives at stake...Should not the FDA be
interested and take action? Why does that seem impossible for JT?